ncibtep@nih.gov

Bioinformatics Training and Education Program

Bold Predictions for Human Genomics by 2030: An NHGRI Seminar Series

Bold Predictions for Human Genomics by 2030: An NHGRI Seminar Series

 When: Mar. 8th, 2021 3:00 pm - 4:30 pm

To Know

Where:
Online Webinar
Organizer:
NHGRI
This class has ended.

About this Class

Zoom Registration Description NHGRI will host a new seminar series this year on the “Bold Predictions for Human Genomics by 2030” that are described in NHGRI’s “Strategic Vision for Improving Human Health at the Forefront of Genomics.” The March 8, 2021 seminar will focus on Bold Prediction #2: The biological function(s) of every human gene will be known; for non-coding elements in the human genome, such knowledge will be the rule rather than the exception. Dr. Nancy Cox of Vanderbilt University and Dr. Neville Sanjana of the NY Genome Center will use this prediction as an aspirational theme for their talks, highlighting their own research in the context of that theme and speculating about the next decade in their research area. The talks will be followed by a moderated question-and-answer session. All seminars will be open to the public and recorded for posting on GenomeTV. Our Speakers Name: Nancy Cox, Ph.D. Organization: Vanderbilt University Biosketch: Dr. Nancy Cox is Director of the Vanderbilt Genetics Institute, Director of the Division of Genetic Medicine, and the Mary Phillips Edmonds Gray Professor of Genetics at Vanderbilt University. She is a quantitative human geneticist with a long-standing research program in identifying and characterizing the genetic component to common human diseases. Name: Neville Sanjana, Ph.D. Organization: NY Genome Center Biosketch: Dr. Neville Sanjana is a Core Faculty Member at the New York Genome Center. He holds a joint appointment as Assistant Professor in the Department of Biology at New York University and is an Assistant Professor of Neuroscience and Physiology at the NYU School of Medicine. As a bioengineer, Dr. Sanjana is focused on creating new tools to understand the impact of genetic changes on the nervous system and cancer evolution.